SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950134-06-003068
Filing Date
2006-02-15
Accepted
2006-02-14 17:37:16
Documents
1
Group Members
ALEXANDER E BARKASDAVID SCHNELLJAMES B TANANBAUMPROSPECT MANAGEMENT CO III LLCRUSSELL C HIRSCH

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE 13G f17360sc13gza.htm SC 13G/A 132826
  Complete submission text file 0000950134-06-003068.txt   134868
Mailing Address 435 TASSO ST SUITE 200 PALO ALTO CA 94301
Business Address 435 TASSO ST SUITE 200 PALO ALTO CA 94301 650-327-8800
Prospect Venture Partners III L P (Filed by) CIK: 0001311490 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A

Mailing Address 12750 HIGH BLUFF DRIVE, SUITE 310 SAN DIEGO CA 92130
Business Address 12750 HIGH BLUFF DRIVE, SUITE 310 SAN DIEGO CA 92130 (858) 509-3670
Somaxon Pharmaceuticals, Inc. (Subject) CIK: 0001339455 (see all company filings)

IRS No.: 200161599 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81290 | Film No.: 06617868
SIC: 2834 Pharmaceutical Preparations